Skip to content

Clinical trials

Completed Fatty Liver trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fatty Liver Status: Completed Country / region: China Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20151
20171
20191
20212
20244
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Zhejiang Chinese Medical University2
Beijing Jishuitan Hospital1
Hongsheng Tan1
Sagimet Biosciences Inc.1
Shanghai Municipal Hospital of Traditional Chinese Medicine1
Shanghai Public Health Clinical Center1
Shanghai Zhongshan Hospital1
The Third Xiangya Hospital of Central South University1
Tsinghua University1
Xijing Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fatty Liver11
Binge Drinking2
Metabolic Syndrome2
Non-alcoholic Fatty Liver Disease2
Autoimmune Diseases1
Chronic Disease1
End Stage Liver Disease1
Gallstones1
Glucose Metabolism Disorders1
Hypertension1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.